» Authors » Kenneth Wester

Kenneth Wester

Explore the profile of Kenneth Wester including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 4628
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Nestor M, Ekberg T, Dring J, van Dongen G, Wester K, Tolmachev V, et al.
Tumour Biol . 2007 Nov; 28(5):253-63. PMID: 17992053
Background: In the growing field of tumor targeting, there is an urgent need to profile suitable molecular targets. In this study, CD44v6 and EGFR expression was quantified in samples of...
22.
Wei Q, Chen L, Sheng L, Nordgren H, Wester K, Carlsson J
Int J Oncol . 2007 Aug; 31(3):493-9. PMID: 17671674
The expression of EGFR, HER2 and HER3 receptors were analyzed in immunohistochemical preparations from primary esophageal tumours and corresponding lymph node metastases. The goal was to evaluate whether any of...
23.
Dyrskjot L, Zieger K, Real F, Malats N, Carrato A, Hurst C, et al.
Clin Cancer Res . 2007 Jun; 13(12):3545-51. PMID: 17575217
Purpose: Clinically useful molecular markers predicting the clinical course of patients diagnosed with non-muscle-invasive bladder cancer are needed to improve treatment outcome. Here, we validated four previously reported gene expression...
24.
Stromberg S, Bjorklund M, Asplund C, Skollermo A, Persson A, Wester K, et al.
Proteomics . 2007 Jun; 7(13):2142-50. PMID: 17549799
Advances in antibody production render a growing supply of affinity reagents for immunohistochemistry (IHC), and tissue microarray (TMA) technologies facilitate simultaneous analysis of protein expression in a multitude of tissues....
25.
Schultz I, de Kok J, Witjes J, Babjuk M, Willems J, Wester K, et al.
Anticancer Res . 2007 May; 27(2):1051-8. PMID: 17465243
Background: The prediction of tumor recurrence in patients with Ta urothelial cell carcinoma is inaccurate and new prognostic markers are desirable. Materials And Methods: Surface-enhanced laser-desorption ionization time-of-flight mass spectrometry...
26.
Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius K, Jarvius J, et al.
Nat Methods . 2006 Oct; 3(12):995-1000. PMID: 17072308
Cellular processes can only be understood as the dynamic interplay of molecules. There is a need for techniques to monitor interactions of endogenous proteins directly in individual cells and tissues...
27.
Andersson A, Stromberg S, Backvall H, Kampf C, Uhlen M, Wester K, et al.
J Histochem Cytochem . 2006 Sep; 54(12):1413-23. PMID: 16957166
Tissue microarray (TMA) technology provides a possibility to explore protein expression patterns in a multitude of normal and disease tissues in a high-throughput setting. Although TMAs have been used for...
28.
Larsson K, Wester K, Nilsson P, Uhlen M, Hober S, Wernerus H
J Immunol Methods . 2006 Sep; 315(1-2):110-20. PMID: 16949094
Monospecific antibodies dfdfdfdf (msAbs) generated through antigen specific purification of polyclonal antisera are valuable tools in proteome analyses. However, proteome wide generation of msAbs would require extensive immunization programs. Therefore,...
29.
Schultz I, Wester K, Straatman H, Kiemeney L, Babjuk M, Mares J, et al.
Eur Urol . 2006 Aug; 51(2):416-22. PMID: 16920253
Objectives: The individual recurrence-free period after primary surgery of patients with Ta urothelial cell carcinoma (UCC) cannot be predicted accurately. This study aims at discriminating between patients with primary Ta...
30.
Schultz I, Wester K, Straatman H, Kiemeney L, Babjuk M, Mares J, et al.
Int J Cancer . 2006 May; 119(8):1915-9. PMID: 16721812
Accurate prediction of tumor recurrence in patients with superficial urothelial cell carcinoma (UCC) might result in a significant reduction of invasive follow-up cystoscopies. A recent study identified a panel of...